Keywords: CKD; chronic kidney disease; ESRD; end-stage renal disease; PSA; polysaccharides; CVD; cardiovascular disease; IS; indoxyl sulfate; TMAO; trimethylamine-N-oxide; SCFA; short chain fatty acid; PCS; p-cresol sulfate; Tregs; regulatory T cells; IRI; ischemia